Compare ZD & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZD | BHVN |
|---|---|---|
| Founded | 1995 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 1999 | 2022 |
| Metric | ZD | BHVN |
|---|---|---|
| Price | $44.56 | $9.90 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 14 |
| Target Price | ★ $39.71 | $29.08 |
| AVG Volume (30 Days) | 502.0K | ★ 1.7M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.08 |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $1,364,028,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.16 | N/A |
| P/E Ratio | $75.97 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $22.45 | $7.48 |
| 52 Week High | $50.55 | $18.57 |
| Indicator | ZD | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 57.92 | 56.69 |
| Support Level | $39.78 | $9.26 |
| Resistance Level | $45.26 | $10.41 |
| Average True Range (ATR) | 1.72 | 0.59 |
| MACD | 0.14 | 0.07 |
| Stochastic Oscillator | 80.75 | 85.27 |
Ziff Davis Inc is a digital media and internet company operating a portfolio of brands across technology, shopping, gaming and entertainment, health and wellness, connectivity, and cybersecurity. The company has five reportable segments. The Technology & Shopping segment generates revenue from advertising and commerce content. The Gaming & Entertainment segment provides content, subscriptions, and digital storefront services. The Health & Wellness segment offers digital tools and content for health management. The Connectivity segment provides data and analytics solutions for network performance. The Cybersecurity & Martech segment delivers cloud-based software for security and marketing. It generates the majority of its revenue from the Health & Wellness segment.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.